| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |